DYN
Dyne Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.11
−5.26%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.88
- Revenue estimate
- —
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- -$1.08
- EPS estimate
- -$0.75
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -13.0%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $26
- PT range
- $10 – $36
- Analysts
- 6
5 Buy0 Hold1 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | -$0.75 | -$1.08 | Miss -44.23% | — |
| May 11, 2026 | -$0.77 | -$0.73 | Beat 5.48% | — |
| Nov 5, 2025 | -$0.81 | -$0.76 | Beat 6.17% | — |
| May 8, 2025 | -$0.88 | -$1.05 | Miss -19.32% | — |
| Feb 27, 2025 | -$0.92 | -$0.88 | Beat 4.35% | — |
| May 2, 2024 | -$0.81 | -$0.81 | In line | — |
| Mar 5, 2024 | -$0.92 | -$1.09 | Miss -18.48% | $3.8M |
| Aug 3, 2023 | -$0.81 | -$1.08 | Miss -33.33% | — |
| May 11, 2023 | -$0.77 | -$0.78 | Miss -1.30% | — |
| Mar 2, 2023 | -$0.84 | -$0.74 | Beat 11.90% | — |
| Nov 3, 2022 | -$0.95 | -$0.80 | Beat 15.79% | — |
| Aug 4, 2022 | -$0.79 | -$1.01 | Miss -27.85% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026